Home
Zentiva

Zentiva Market Share Analysis for July 2026

Zentiva, a leading European generics pharmaceutical company, Advent and GTCR – two leading global private equity investors – today announce the sale of Zentiva by Advent to GTCR.

Health > Biotechnology and Pharmaceuticals

Domainzentiva.com

Year Founded2003

Employees5001 - 10000

Annual Revenue$100M - $200M

Zentiva

Zentiva (including company regionals)

zentiva.com

See more website traffic and engagement information

Zentiva Revenue up to July 2026 is 100M - 200M

revenue generated by Zentiva top domains

Zentiva top domains revenue over 3 years

Revenue for Zentiva top domains

zentiva.com100M - 200M

See more with Sales Intelligence

Total visits to Zentiva's top domains

Understand Zentiva market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

zentiva.com26.6K

See more with Sales Intelligence

Avg. visit duration in Zentiva's top domains

Analyze Zentiva engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

zentiva.com00:00:57

See more with Sales Intelligence

Avg. pageviews on Zentiva's top domains

See how Zentiva keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

zentiva.com2.08

See more with Sales Intelligence

Zentiva top competitors by domain

Top similar sites in July 2026, ranked by their affinity

galen.bgCompany NameGalen PharmaciesEmployees201 - 500HQBulgaria, SofiaAnnual revenue--Total visits1.6MHealth > Nutrition Diets and Fitness

Top technologies used by Zentiva

These are the website technologies, by industry, used by Zentiva top domains

Conversion & Analytics (5)

Google Analytics

Email Services (3)

Microsoft Exchange Online

Payment & Currencies (3)

Euro

Content Management System (2)

Atlassian Cloud

More Technologies

10

See all

News & Signals from Zentiva

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsZentiva Group receives award ESG Transparency Award 2025.Demonstrating accountability: Zentiva receives prestigious ESG Transparency Award 2025.

NewsBoehringer Ingelheim Pharmaceuticals, Inc. filed suit against Zentiva on Sep 24th '25.On that basis, Boehringer Ingelheim applied for a preliminary injunction against Zentiva in all UPC states in which the patent is in force.

NewsGTCR acquired Zentiva Group for $4.8B on Sep 17th '25.Private equity heavyweight GTCR has agreed to acquire Czech generic drugmaker Zentiva from Advent International in a deal worth €4.1 billion ($4.8 billion), the Financial Times reported Wednesday, citing sources close to the matter.